Clinical trial NCT01810510: Impact of PAV Versus NAVA on Patient-Ventilator Synchrony and Respiratory Muscle Unloading
Official title: Impact of PAV Versus NAVA on Patient-Ventilator Synchrony and Respiratory Muscle Unloading
Study type: INTERVENTIONAL
Overall status: WITHDRAWN
Phase: NA
Conditions: Respiratory Failure
Keywords: respiration, artificial
Lead sponsor: Massachusetts General Hospital
Sponsor class: OTHER
First posted: 2013-03-13
Enrollment: 0
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: SUPPORTIVE_CARE

Brief summary: The purpose of this study is to determine whether two modes of artificial (i.e. mechanical) ventilation have an impact on patient synchrony with the ventilator (breathing machine) and on the patient's work of breathing.

Detailed description: New, "intelligent" ventilator modes with more complex closed loops have been developed, some with a demonstrated clinical benefit. The modes of proportional assist ventilation (PAV) and neurally-adjusted ventilatory assist (NAVA) are capable of delivering ventilation proportional to patient effort and may be associated with improved patient-ventilator synchrony when compared to pressure support ventilation (PSV), a classic simple closed-loop assisted ventilation mode.

This study will study both modes of ventilation (PAV and NAVA) in each patient who is recruited, and measures of patient-ventilator synchrony and work of breathing will be taken during each mode.

Baseline data will be collected on a standardized volume-cycled control mode ventilator setting for 5 minutes and on a standardized pressure support ventilator mode for 25 minutes. Subjects will then be randomized to either PAV or NAVA ventilation and will be ventilated on that mode for 30 minutes. Equivalence of support levels between PAV and NAVA trials will be ensured by targeting the same peak (Ppeak) airway pressures. Data collected will include (but are not limited to) vital signs, sedation score, dyspnea assessment using visual analog scale, respiratory rate, tidal volume (Vt), peak airway pressure (Ppeak), inspiratory time and neural inspiratory time (Ti and Tni), total physiologic and neural respiratory cycle time (Ttot and Tntot), end-tidal CO2, esophageal pressure waveforms, waveforms of all ventilatory patterns, Edi waveforms, and peak Edi. Subjects will then be switched to the other mode of ventilation and undergo an identical 30-minute evaluation period with identical data collection. Arterial blood gas measurements will be done after any changes in ventilator settings only in subjects who have had arterial lines inserted for clinically-indicated reasons. This will be a replicate crossover study, meaning that all subjects that are initially randomized to one sequence (PAV-NAVA or NAVA-PAV) will afterwards be "crossed-over" to the other one. These two additional periods of measurements will allow us to account for potential carry over effects of the different interventions.

Eligibility criteria: Inclusion Criteria:

* Age 18 years or older
* Respiratory failure requiring mechanical ventilation
* Spontaneously breathing (able to generate flow/ pressure/ volume triggers on control modes of ventilation or on a mode of mechanically assisted spontaneous breathing)
* Requiring FiO2\< 60% and PEEP\< 10cm H2O to maintain oxygen saturations \>90%

Exclusion Criteria:

* Pregnancy
* Inability to tolerate spontaneous breathing
* Gastro-esophageal pathology (including but not limited to recent gastric or esophageal surgery, history of varices, known anatomical gastric or esophageal defects such as strictures, hernias or fistulas)
* Agitation necessitating major sedative infusions
* Hemodynamic instability necessitating active adjustments in vasopressor therapy
* Coagulopathy
* New intracranial pathology (stroke, hemorrhage, meningitis, encephalitis)
* Paralyzed diaphragm

Primary outcomes:
measure: Patient-Ventilator Synchrony
timeFrame: 2.5 hours
Secondary outcomes:
measure: Dyspnea Index
timeFrame: 2.5 hours
measure: Respiratory Muscle Unloading
timeFrame: 2.5 hours
Other outcomes:
Locations:
city: Boston
country: United States
facility: Massachusetts General Hospital
state: Massachusetts
Study officials:
affiliation: Massachusetts General Hospital
name: Robert S Harris, MD
role: PRINCIPAL_INVESTIGATOR
References: